Trekka Therapeutics, Inc.
PrivateLast Round
Series A
Feb 5, 2024
Total Funding Raised
$548,000
Company Overview
Trekka Therapeutics, Inc. is a biotechnology company that develops proprietary polymeric drug delivery platforms, CAPRO™ and MORE™, to improve the formulation, solubility, and delivery of small molecule drugs and biologics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Advanced Materials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Trekka Therapeutics, Inc. Comparables
Compare Trekka Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Consegna Pharma Inc. | 81% | |
| CURE Pharmaceutical | 77% | |
| Nualtis | 77% |
Trekka Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 5, 2024 |
Trekka Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
Trekka Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Trekka Therapeutics, Inc.'s valuation, stock price, and market status.
Is Trekka Therapeutics, Inc. a public or private company?
Trekka Therapeutics, Inc. is a private company.
What is the current stock price of Trekka Therapeutics, Inc.?
Trekka Therapeutics, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Trekka Therapeutics, Inc. worth (valuation)?
Valuation information for Trekka Therapeutics, Inc. is not publicly available.
Can I buy Trekka Therapeutics, Inc. stock?
Trekka Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Trekka Therapeutics, Inc.'s last funding round?
Trekka Therapeutics, Inc.'s most recent funding round was Series A on February 5, 2024.
Who are the main investors in Trekka Therapeutics, Inc.?
Key investors in Trekka Therapeutics, Inc. include NIH RADx.
Will Trekka Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for Trekka Therapeutics, Inc..
How can I track Trekka Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Trekka Therapeutics, Inc.'s secondary market activity and sign up for updates.